Inflammation und Immunschwäche bei neuropsychiatrischen Erkrankungen

Zahlreiche Forschungsarbeiten bestätigen das Vorliegen von Inflammation und Immunschwäche bei CFS/CFIDS und anderen neuropsychiatrischen Erkrankungen. Die deutschen Leit- und Richtlinien, die hier eine Immun- und Erregerdiagnostik verbieten, müssen daher als überholt und unwissenschaftlich betrachtet werden.

• Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype
• How Inflammatory Disease Causes Fatigue: chronic inflammation infiltrates the brain but can be blocked
• Immune System and Schizophrenia
• Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?
• From inflammation to sickness and depression: when the immune system subjugates the brain
• Changes in behaviour and cytokine expression upon a peripheral immune challenge.
• Loss of stress response as a consequence of viral infection: implications for disease and therapy.
• Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior.
• The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders - relation to drug treatment
• Neuroplastic changes in depression: A role for the immune system
• Changes in the immune system in depression and dementia: causal or co-incidental effects?
• Altered monocyte activation markers in Tourette’s syndrome: a case–control study
• The gut-brain barrier in major depression: Intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression

 

Hier wird noch gearbeitet. Weitere Sparten befinden sich in Vorbereitung.